According to Syndax Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.21 B. In 2022 the company made an earning of -$0.15 B a decrease over its 2021 earnings that were of $24.92 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.21 B | 40.19% |
2022 | -$0.15 B | -699.13% |
2021 | $24.92 M | -134.07% |
2020 | -$73.16 M | 30.53% |
2019 | -$56.05 M | -24.22% |
2018 | -$73.97 M | 21.64% |
2017 | -$60.81 M | 36.72% |
2016 | -$44.48 M | 84.39% |
2015 | -$24.12 M | 21.64% |
2014 | -$19.83 M | 39.92% |
2013 | -$14.18 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -47.09% | ๐บ๐ธ USA |